Materialise appears positioned for stable revenue generation, evidenced by a consistent gross margin averaging ~57% and a recent Q2 2026 revenue growth of 9.9%. However, investors should monitor the company's persistent inability to translate this into operati...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 27, 2026 | $0.07+53.2% vs $0.05 | $80M+2.3% vs $78M |
Q3 2026 Jul 23, 2026 | $0.07+45.4% vs $0.05 | $81M+4.1% vs $78M |
Q2 2026 May 7, 2026 | $0.03+200.1% vs $0.01 | $77M-0.6% vs $77M |
Q1 2026 Feb 19, 2026 | $0.12+70.3% vs $0.07 | $82M-0.8% vs $83M |
Materialise NV (NASDAQ: MTLS - Get Free Report) shares passed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $6.81 and traded as high as $7.67. Materialise shares last traded at $7.56, with a volume of 215,420 shares traded. Analysts Set New Price Targets A number of
Materialise (NASDAQ: MTLS) reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses. Chief
Materialise NV (MTLS) Q2 2026 Earnings Call Transcript
Materialise NASDAQ: MTLS reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses.
Benchmark MTLS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Materialise N.V. (MTLS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.78 | $455.56M | 52.19 | -3.63% | 2.88% | 2.94% | — | |
| $7.91 | $686.7M | -6.18 | -3.73% | -21.05% | -13.8% | — | |
| $3.48 | $568.42M | 18.32 | -12.09% | -14.15% | -22.53% | — | |
| $1.55 | $326.29M | -1.13 | 77.3% | -134.86% | -30.72% | — | |
| $99.53 | $5.35B | -81.58 | 25.87% | -3.82% | -8.63% | — | |
| $135.28 | $15.63B | 22.25 | 19.18% | 41.43% | 32.64% | — |
Materialise N.V. (MTLS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when MTLS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Materialise N.V. (MTLS) stock FAQ — growth, dividends, profitability & financials explained
Materialise N.V. (MTLS) reported $275.2M in revenue for fiscal year 2025. This represents a 366% increase from $59.1M in 2012.
Materialise N.V. (MTLS) saw revenue decline by 3.6% over the past year.
Yes, Materialise N.V. (MTLS) is profitable, generating $13.3M in net income for fiscal year 2025 (2.9% net margin).
Materialise N.V. (MTLS) has a return on equity (ROE) of 2.9%. This is below average, suggesting room for improvement.
Materialise N.V. (MTLS) generated $16.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
